x
.png){kind=small}
The only autonomous diabetic retinopathy screening solution that is portable
Screen patients at-home and instantly receive a diagostic result from the FDA-cleared AI
See Aurora AEYE in action
Portable camera enabling point of screening, anywhere, whether at home or in-clinic
Internet-connected camera automatically processes exams and provide a diagnostic result on the spot
Advantages of Aurora-AEYE
Accessible
Enables point of care screenings anywhere, whether at home or in-clinic
_edited.png)
1-minute Screening
Requires only one image per eye; rarely requires dilation; producing instant diagnosis
_edited.png)
Indications for Use
The AEYE-DS is indicated for use by health care providers to automatically detect more than mild diabetic retinopathy (mtmDR) in adults diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy. AEYE-DS is indicated for use with the Topcon NW400 camera and the Optomed Aurora camera.
Accuracy & Usability
In an FDA clinical study assessing the detection of more-than-mild diabetic retinopathy, the AEYE-DS exhibited sensitivity range of 92%-93% and specificity range of 89%-94 93% when utilizing a single image per eye with the Optomed Aurora camera.
How it works
3
2
1
Image
A single image per eye is obtained with the Aurora camera
Analyze
Images are analyzed by the AEYE-DS AI
Result
Diagnostic result returned in under a minute
.png)
